P3 Health Partners Inc. (PIII): Nasdaq/NYSE listing notice — P3 Health Partners receives Nasdaq deficiency notice for failing to meet minimum stockholders' equity requirement
P3 Health Partners Inc.
On Nov 21, 2025, Nasdaq notified P3 Health Partners that it lacks the $2.5M minimum stockholders' equity required by Listing Rule 5550(b)(1).
Company also does not meet the alternatives of market value of listed securities or net income from continuing operations.
Letter has no immediate delisting effect; company has 45 calendar days to submit a plan to regain compliance.
If plan accepted, Nasdaq may grant an extension of up to 180 calendar days from Nov 21, 2025 to evidence compliance.
Company intends to submit a compliance plan and is pursuing steps to restore compliance, though no assurance of success.
P3 Health Partners Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
November 21, 2025, P3 Health Partners Inc. (the “Company”) received a letter (the “Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notified the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(1) (the “Listing Rule”), which requires that the Company maintain a minimum of $2.5 million in stockholders’ equity, and that the Company also does not meet the alternatives of market value of listed securities or net income from continuing operations set forth in the Listing Rule. The Letter does
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.